BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30024510)

  • 21. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW
    Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study.
    Hur SH; Won KB; Kim IC; Bae JH; Choi DJ; Ahn YK; Park JS; Kim HS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Gwon HC; Rha SW; Jang W; Bae JW; Hwang KK; Lim DS; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS;
    Medicine (Baltimore); 2016 Jun; 95(25):e3882. PubMed ID: 27336875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction.
    Lee JW; Choi E; Khanam SS; Son JW; Youn YJ; Ahn MS; Ahn SG; Kim JY; Lee SH; Yoon J; Yoo BS
    Int J Cardiol; 2019 Aug; 289():19-23. PubMed ID: 30638981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
    Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic importance of mitral regurgitation complicated by acute myocardial infarction during a 5-year follow-up period in the drug-eluting stent era.
    Kim TH; Lee KY; Choi Y; Park HW; Lee YS; Koh YS; Park HJ; Kim PJ; Chang K; Chung WS; Kim DB; Her SH; Park CS; Lee JM; Kim HY; Yoo KD; Jeon DS; Ahn Y; Jeong MH; Seung KB
    Coron Artery Dis; 2016 Mar; 27(2):109-15. PubMed ID: 26626143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.
    Parashar A; Agarwal S; Krishnaswamy A; Sud K; Poddar KL; Bassi M; Ellis S; Tuzcu EM; Menon V; Kapadia SR
    J Am Coll Cardiol; 2016 Jul; 68(4):329-38. PubMed ID: 27443427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. γ-Glutamyl Transferase and Long-Term Survival in the SYNTAXES Trial: Is It Just the Liver?
    Ninomiya K; Serruys PW; Garg S; Kageyama S; Kotoku N; Masuda S; Revaiah PC; O'leary N; Kappetein AP; Mack MJ; Holmes DR; Davierwala PM; Mohr FW; Thuijs DJFM; Onuma Y;
    J Am Heart Assoc; 2024 Apr; 13(8):e032276. PubMed ID: 38563386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.
    Yamac AH; Sevgili E; Kucukbuzcu S; Nasifov M; Ismailoglu Z; Kilic E; Ercan C; Jafarov P; Uyarel H; Bacaksiz A
    Herz; 2015 Sep; 40(6):912-20. PubMed ID: 25911051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impacts of inhibition of renin-angiotensin system in patients with acute ST-segment elevation myocardial infarction who underwent successful late percutaneous coronary intervention.
    Park H; Kim HK; Jeong MH; Cho JY; Lee KH; Sim DS; Yoon NS; Yoon HJ; Hong YJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kim YJ; Cho MC; Kim CJ;
    J Cardiol; 2017 Jan; 69(1):216-221. PubMed ID: 27141820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
    Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR
    Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1264-1275. PubMed ID: 30474346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
    Hur SH; Kim IC; Won KB; Cho YK; Yoon HJ; Nam CW; Kim KB; Kim MS; Park J; Rha SW; Chae SC; Kim YJ; Kim CJ; Cho MC; Jeong MH; Ahn YK; Kim HS; Ahn TH; Seung KB; Jang Y; Yoon JH; Seong IW; Hong TJ; Bae JH; Park SJ;
    Clin Cardiol; 2016 May; 39(5):276-84. PubMed ID: 27028303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
    Bagai A; Armstrong PW; Stebbins A; Mahaffey KW; Hochman JS; Weaver WD; Patel MR; Granger CB; Lopes RD
    Am Heart J; 2013 Nov; 166(5):913-9. PubMed ID: 24176448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.